Home/Cardiology CME/CE Webinar/DROP Asian ACS – Validation of the ESC 0/1-Hour Algorithm for Chest Pain Triage in Asian EDs

DROP Asian ACS – Validation of the ESC 0/1-Hour Algorithm for Chest Pain Triage in Asian EDs

Cardiology CME/CE Webinar
proCardio Asia Pacific

Key Takeaways

  • The ESC 0/1-hour hs-cTn algorithm accelerates risk stratification in patients with suspected NSTE-ACS, with noninferior 30-day MACE outcomes compared with usual care, supporting the safety of the algorithm. [1]
  • Approximately 50% of patients are ruled out within 1 hour, with negligible 30-day event rates, supporting early discharge decisions and reducing ED overcrowding.[1]
  • Rule-in patients are enriched for NSTEMI, enabling faster invasive management and reducing diagnostic uncertainty through objective rapid triage.[1]
  • Successful implementation relies on protocol adherence and workflow integration, offering a simple and scalable strategy to improve resource and cost efficiencies. [1]

This section presents a concise, high-yield summary of the video’s core content, designed as a quick reference for Healthcare Professionals (HCPs).

Note: This content was developed by our editorial team and was not reviewed or endorsed by the video speaker.


Q1. What clinical problem does the 0/1-hour algorithm aim to solve?
Chest pain triage remains slow, variable, and resource-intensive in many Asian EDs. Conventional troponin protocols require serial testing over several hours, contributing to overcrowding, higher admission rates, and delayed invasive management in true ACS patients. [1]

Q2. How does the ESC 0/1-hour algorithm work?
It measures hs-cTn at baseline and again at 1 hour. Using assay-specific cut-offs and delta changes, patients are rapidly classified as Rule-Out, Observe, or Rule-In for suspected NSTE-ACS, enabling actionable decisions within a short diagnostic window. [1]

Q3. How did the algorithm perform in the DROP-Asian trial?
The algorithm has been proven to safely rule out approximately half of patients with negligible 30-day event rates and enriched the Rule-In cohort for NSTEMI. Non-inferiority to usual care was demonstrated for 30-day MACE, with no emergent safety signals. [1]

Q4. Does the algorithm reduce admissions or ED congestion?
Admission rates were lower under 0/1-hour care, and the diagnostic clarity achieved within 1 hour supports potential improvements in throughput. ED length of stay remained similar overall due to variable clinician adherence and workflow constraints.[1]

Q5. Why is adherence important?
In Rule-In patients, failure to follow algorithmic guidance corresponded with higher MI events within 30 days. These findings highlight that biomarker precision must be matched by implementation fidelity to achieve intended clinical outcomes. [1]

Q6. Does the algorithm require region-specific troponin thresholds?
No. Assay-specific thresholds remain essential, but no distinct “Asian cut-off” biology emerged. The trial reinforces global hs-cTn standardization rather than regional customization.[1]

Q7. How does the algorithm compare to existing guideline pathways?
Many Asian countries still rely on 0/3-hour protocols, often without consistent adherence. The 0/1-hour strategy accelerates diagnostic certainty and aligns Asian practice with contemporary standards. [2]

Q8. What are the health-system implications?
Faster triage, lower admissions, and reduced resource utilization may yield economic benefits and relieve ED overcrowding. Additional gains may occur if paired with workflow reform and education. [1]

Q9. What is the overarching clinical message?
The ESC 0/1-hour hs-cTn algorithm has been proven to be a safe, efficient, and scalable approach for chest pain triage in Asian EDs. It modernizes ACS evaluation, reduces uncertainty, and supports better resource allocation without compromising patient safety. [1]

References

  1. Inoue K, Twerenbold R, Kasim S, et al. Validation of the European Society of Cardiology 0/1-hour algorithm for chest pain triage in Asian emergency departments: a multinational stepped-wedge cluster-randomised trial. Heart. Published online November 23, 2025. doi:10.1136/heartjnl-2025-326594
  2. Rao SV, O’Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151(13):e771-e862. doi:10.1161/CIR.0000000000001309